Education
About Us
Working with TipRanks
Follow Us
Quest Diagnostics (DGX)
NYSE:DGX
DGX Stock Chart & Stats
Day’s Range― - ―
52-Week Range$146.17 - $185.62
Previous CloseN/A
Volume143.08K
Average Volume (3M)1.19M
Market Cap
$20.17B
Enterprise Value$26.48B
Total Cash (Recent Filing)$319.00M
Total Debt (Recent Filing)$6.38B
Price to Earnings (P/E)21.4
Beta0.26
Next Earnings
Oct 28, 2025EPS Estimate
2.5Next Dividend Ex-Date
Oct 03, 2025Dividend Yield1.72%
Share Statistics
EPS (TTM)2.62
Shares Outstanding111,823,440
10 Day Avg. Volume850,837
30 Day Avg. Volume1,185,841
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.31
Enterprise Value/Revenue2.52
Enterprise Value/Gross Profit7.62
Enterprise Value/Ebitda13.76
Forecast
1Y Price Target
$189.09Price Target Upside4.84% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering12
Bulls Say, Bears Say
Bulls Say
EarningsQuest Diagnostics reported strong second-quarter results with sales and adjusted earnings per share exceeding expectations, driven by significant revenue growth through healthcare provider channels and expanded payer access.
GrowthContinued strong utilization trends, increased demand, and expansion of enterprise accounts all contributed to growth.
GuidanceFull-year guidance for both revenue and earnings was raised by more than the beats in the second-quarter update.
Bears Say
Legislative ImpactsThe outlook over the near- and long-term remains intact despite potential headwinds from legislative impacts.
Regulatory ChallengesPotential macro changes tied to eroding Medicaid/HIX volumes are seen as potential headwinds for DGX.
Quest Diagnostics News
DGX FAQ
What was Quest Diagnostics’s price range in the past 12 months?
Quest Diagnostics lowest stock price was $146.17 and its highest was $185.62 in the past 12 months.
What is Quest Diagnostics’s market cap?
Quest Diagnostics’s market cap is $20.17B.
When is Quest Diagnostics’s upcoming earnings report date?
Quest Diagnostics’s upcoming earnings report date is Oct 28, 2025 which is in 61 days.
How were Quest Diagnostics’s earnings last quarter?
Quest Diagnostics released its earnings results on Jul 22, 2025. The company reported $2.62 earnings per share for the quarter, beating the consensus estimate of $2.57 by $0.05.
Is Quest Diagnostics overvalued?
According to Wall Street analysts Quest Diagnostics’s price is currently Undervalued.
Does Quest Diagnostics pay dividends?
Quest Diagnostics pays a Quarterly dividend of $0.8 which represents an annual dividend yield of 1.72%. See more information on Quest Diagnostics dividends here
What is Quest Diagnostics’s EPS estimate?
Quest Diagnostics’s EPS estimate is 2.5.
How many shares outstanding does Quest Diagnostics have?
Quest Diagnostics has 111,823,440 shares outstanding.
What happened to Quest Diagnostics’s price movement after its last earnings report?
Quest Diagnostics reported an EPS of $2.62 in its last earnings report, beating expectations of $2.57. Following the earnings report the stock price went up 7.083%.
Which hedge fund is a major shareholder of Quest Diagnostics?
Currently, no hedge funds are holding shares in DGX
Quest Diagnostics Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$189.09 (4.84% Upside)
$189.09 (4.84% Upside)
Blogger Sentiment
Bullish
DGX Sentiment 66%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 1.4M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 5.5%
Last 30 Days ▲ 2.6%
Last 30 Days ▲ 2.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
19.46%
12-Months-Change
Fundamentals
Return on Equity
13.65%
Trailing 12-Months
Asset Growth
15.04%
Trailing 12-Months
Company Description
Quest Diagnostics
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
DGX Company Deck
DGX Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
Quest Diagnostics reported strong top-line and bottom-line growth driven by strategic acquisitions, operational improvements, and expansion in advanced diagnostics. While there were challenges related to tariffs, wage increases, and potential legislative impacts, the company managed these within its guidance and raised its full-year outlook.View all DGX earnings summariesDGX Revenue Breakdown
97.39% Diagnostic Information Services
2.61% All other operating segments
DGX Stock 12 Month Forecast
Average Price Target
$189.09
▲(4.84% Upside)
Technical Analysis
Ownership Overview
0.43% Insiders
31.50% Mutual Funds
15.44% Other Institutional Investors
24.64% Public Companies and
Individual Investors